217 related articles for article (PubMed ID: 12385967)
1. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
McLachlan A; Cullis PG; Cornell HJ
J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
[TBL] [Abstract][Full Text] [Related]
2. Wheat gliadin fractions and other cereal antigens reactive with antibodies in the sera of coeliac patients.
Kieffer M; Frazier PJ; Daniels NW; Coombs RR
Clin Exp Immunol; 1982 Dec; 50(3):651-60. PubMed ID: 7166001
[TBL] [Abstract][Full Text] [Related]
3. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
[TBL] [Abstract][Full Text] [Related]
4. Bioactive antinutritional peptides derived from cereal prolamins: a review.
Silano M; De Vincenzi M
Nahrung; 1999 Jun; 43(3):175-84. PubMed ID: 10399351
[TBL] [Abstract][Full Text] [Related]
5. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
[TBL] [Abstract][Full Text] [Related]
6. The precipitating factor in coeliac disease.
Wieser H
Baillieres Clin Gastroenterol; 1995 Jun; 9(2):191-207. PubMed ID: 7549024
[TBL] [Abstract][Full Text] [Related]
7. [Spelt wheat and celiac disease].
Forssell F; Wieser H
Z Lebensm Unters Forsch; 1995 Jul; 201(1):35-9. PubMed ID: 7571865
[TBL] [Abstract][Full Text] [Related]
8. Gluten-sensitive enteropathy.
Luchetti R; De Vincenzi M
Ann Ist Super Sanita; 1995; 31(3):323-36. PubMed ID: 8712576
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-gliadin-derived peptides from bread and durum wheat on K562(S) cells.
Dessi M; De Vincenzi M; Maialetti F; Mancini E
Ital J Gastroenterol; 1992 Sep; 24(7):397-9. PubMed ID: 1392022
[TBL] [Abstract][Full Text] [Related]
10. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol.
Valdés I; García E; Llorente M; Méndez E
Eur J Gastroenterol Hepatol; 2003 May; 15(5):465-74. PubMed ID: 12702901
[TBL] [Abstract][Full Text] [Related]
11. [Comparative toxicity of different cereals for subjects intolerant of gluten].
Charbonnier L; Jos J; Mougenot JF; Mossé J
Reprod Nutr Dev (1980); 1980; 20(4B):1369-77. PubMed ID: 6818635
[TBL] [Abstract][Full Text] [Related]
12. Chemistry, coeliac-toxicity and detection of gluten and related prolamins in foods.
Skerritt JH; Devery JM; Hill AS
Panminerva Med; 1991; 33(2):65-74. PubMed ID: 1923557
[TBL] [Abstract][Full Text] [Related]
13. Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.
Ellis HJ; Doyle AP; Sturgess RP; Ciclitira PJ
Gut; 1992 Nov; 33(11):1504-7. PubMed ID: 1280610
[TBL] [Abstract][Full Text] [Related]
14. Coeliac Disease: background and biochemical aspects.
Hamer RJ
Biotechnol Adv; 2005 Sep; 23(6):401-8. PubMed ID: 16006084
[TBL] [Abstract][Full Text] [Related]
15. A small peptide from durum wheat gliadin prevents cell agglutination induced by prolamin-peptides toxic in coeliac disease.
De Vincenzi M; Gasbarrini G; Silano V
Toxicology; 1997 Jul; 120(3):207-13. PubMed ID: 9217307
[TBL] [Abstract][Full Text] [Related]
16. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
[TBL] [Abstract][Full Text] [Related]
17. A radioimmunoassay for wheat gliadin to assess the suitability of gluten free foods for patients with coeliac disease.
Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
Clin Exp Immunol; 1985 Mar; 59(3):703-8. PubMed ID: 3987095
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley.
Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ
Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270
[TBL] [Abstract][Full Text] [Related]
19. Coeliac disease. Pathogenesis and clinical aspects.
Friis SU
APMIS Suppl; 1996; 61():1-48. PubMed ID: 8765057
[No Abstract] [Full Text] [Related]
20. Extraction of cereal prolamins and their toxicity in coeliac disease.
Cornell HJ; McLachlan A; Cullis PG
J Biochem Mol Biol Biophys; 2002 Apr; 6(2):151-8. PubMed ID: 12186773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
